Showing results (871-880 of 901) with videos related to

Sort By:
Pageof 91
Yonsei Medical Journal|April 4, 2015
The effect of specialized continuous renal replacement therapy team in acute kidney injury patients treatmentYoun Kyung Kee, Eun Jin Kim, Kyoung Sook Park, et al.
Frontiers in Immunology|April 12, 2024
Efficacy and safety of BVAC-C in HPV type 16- or 18-positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa studyChel Hun Choi, Jeong-Won Lee, Duk-Soo Bae, et al.
Gynecologic Oncology|April 3, 2022
Impact of no residual disease on postoperative computed tomography on survival in patients with optimally debulked advanced high-grade serous ovarian cancer during upfront surgeryHyunji Lim, Jung In Shim, Soo Jin Park, et al.
Human Pathology|January 21, 2014
Comparison of the Haas and the Oxford classifications for prediction of renal outcome in patients with IgA nephropathyKyoung Sook Park, Seung Hyeok Han, Jeong Hae Kie, et al.
Science Advances|September 27, 2023
Battery metal recycling by flash Joule heatingWeiyin Chen, Jinhang Chen, Ksenia V Bets, et al.
Kidney International|November 26, 2016
Normal body mass index with central obesity has increased risk of coronary artery calcification in Korean patients with chronic kidney diseaseMi Jung Lee, Jung Tak Park, Kyoung Sook Park, et al.
BMC Nephrology|March 27, 2014
Clinical features and outcomes of focal segmental glomerulosclerosis pathologic variants in Korean adult patientsYoung Eun Kwon, Seung Hyeok Han, Jeong Hae Kie, et al.
BMC Nephrology|June 3, 2014
KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease): design and methodsKook-Hwan Oh, Sue Kyung Park, Hayne Cho Park, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2025
Durvalumab versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): a multicenter, randomized, phase 2 trialNatalie Y L Ngoi, Chel Hun Choi, Junxian Zhu, et al.
Cancer Research|July 19, 2017
HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor CellsKwon-Ho Song, Chel Hun Choi, Hyo-Jung Lee, et al.
Pageof 91